News & Events

You are here

9
May

W. magna, 90% efficacy on mildew

Lyon, 4th Mai 2018 - AMOEBA announces today the first greenhouse test results conducted with the microorganism, Willaertia magna C2c Maky, used as a biocontrol agent for the control of mildew on grapevine.

 The results of the first greenhouse trials show very clear dose-responses of Willaertia magna C2c Maky in a formulated product. The efficacy of more than 90% of the formulated product on mildew has to be compared to the usual efficacy of biocontrol agents of around 50% observed in greenhouses. A new series of tests is scheduled in 2018 in preparation of the field trials planned in 2019. 

These first greenhouse tests, which confirm the previous in vitro trials (see our press release dated November 22, 2017), are a fundamental milestone to validate the potential use of Willaertia magna C2c Maky as an alternative to traditional chemical products. These tests were carried out by CONIDIA, an independent recognized expert in fungi and their resistance to fungicides.

This milestone will enable the Company to...

Read More
22
Nov

Willaertia Magna as a biocontrol agent

Lyon, November 22nd, 2017- AMOEBA announced today the positive results of in vitro trials conducted with Willaertia...

9
Nov

New LOI in Switzerland

Lyon (France), Lancy (Switzerland), November 8th, 2017 - AMOEBA announced today that it has signed a Letter of Intent (LOI) with ...

9
Oct

EIB provides EUR 20m credit line to Amoéba

Lyon, October 9th, 2017 - Amoéba has received financing worth EUR 20m from the EIB. This EIB financing is secured by the...

15
Sep

3rd distribution agreement in Europe

Lyon (France), Rome, September 14th, 2017 - AMOEBA announced today that it has signed a distribution agreement for its BIOMEBA...

25
Aug

Amoéba will be at AWT 2017

Lyon, Friday 25th August 2017 – For the 3rd consecutive year Amoéba will participate at the annual exhibition of industrial water treatment...